Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bristol GDNF Trial in Parkinson's Disease
NCT03652363Phase 2Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Oct 2012
- Primary completion
- Mar 2015
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Placebo Arm with GDNF Arm (2 arms). Primary endpoint: Unified Parkinson's Disease Rating Scale Part III in the OFF state at 40 weeks. Started Oct 2012; status: completed.
02
Drugs
glial cell line-derived neurotrophic factor
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03652363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03652363.